Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Inventory Average (2020 - 2025)

Historic Inventory Average for Eton Pharmaceuticals (ETON) over the last 6 years, with Q3 2025 value amounting to $20.3 million.

  • Eton Pharmaceuticals' Inventory Average rose 91462.81% to $20.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.3 million, marking a year-over-year increase of 91462.81%. This contributed to the annual value of $8.1 million for FY2024, which is 99965.94% up from last year.
  • As of Q3 2025, Eton Pharmaceuticals' Inventory Average stood at $20.3 million, which was up 91462.81% from $18.7 million recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Inventory Average registered a high of $20.3 million during Q3 2025, and its lowest value of $442000.0 during Q4 2021.
  • Its 5-year average for Inventory Average is $4.0 million, with a median of $981000.0 in 2023.
  • As far as peak fluctuations go, Eton Pharmaceuticals' Inventory Average tumbled by 6994.22% in 2021, and later skyrocketed by 91462.81% in 2025.
  • Over the past 5 years, Eton Pharmaceuticals' Inventory Average (Quarter) stood at $442000.0 in 2021, then grew by 17.42% to $519000.0 in 2022, then skyrocketed by 89.02% to $981000.0 in 2023, then skyrocketed by 775.13% to $8.6 million in 2024, then soared by 136.73% to $20.3 million in 2025.
  • Its last three reported values are $20.3 million in Q3 2025, $18.7 million for Q2 2025, and $14.4 million during Q1 2025.